Breast Cancer Resiliency Through Exercise Program (B-REP)
Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study
University of Michigan Rogel Cancer Center
75 participants
May 28, 2024
INTERVENTIONAL
Conditions
Summary
The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
guided exercise program for 12 weeks
Control Arm Waiting List for 24 weeks, then offered a guided exercise program for 12 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06100263